Enhancing the anti-fibrotic and regenerative capacity of bone marrow-derived stem cells

Samuel, Chrishan (Primary Chief Investigator (PCI))
Ricardo, Sharon (Chief Investigator (CI))
Widdop, Robert (Chief Investigator (CI))
Kerr, Peter (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/19 → 31/12/21

2 Article

Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension
Li, Y., Shen, M., Ferens, D., Broughton, B. R. S., Murthi, P., Saini, S., Widdop, R. E., Ricardo, S. D., Pinar, A. A. & Samuel, C. S., Mar 2021, In: British Journal of Pharmacology. 178, 5, p. 1164-1181 18 p.
Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)
Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice
Li, Y., Chakraborty, A., Broughton, B. R. S., Ferens, D., Widdop, R. E., Ricardo, S. D. & Samuel, C. S., Dec 2021, In: Biomedicine & Pharmacotherapy. 144, 12 p., 112256.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

2 Citations (Scopus)

Animal Research Platform (MARP)
Tanya Lennane (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility
Biomedical Imaging (MBI)
Gary Egan (Manager) & Kylie Reid (Manager)
Office of the Vice-Provost (Research and Research Infrastructure)
Facility/equipment: Facility
Histology Platform
Camilla Cohen (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility